About TheraTraQ
TheraTraQ is a Healthcare company based in Reading (United States) founded in 2019. It provides competitive intelligence platforms and analytics for biopharmaceutical clients. It operates on a B2B and SaaS model. The company has 56 employees. Its Indian entity Theratraq India Private Limited reported revenue of ₹12.17 Cr. TheraTraQ offers products and services including IntelliTraQ, PulseTraQ, KOL Match, CellTraQ, and GeneTraQ. Its focus areas include Biotech, Competitive Intelligence, Pharma Analytics and Rare Disease. Its competitors include Knipper, Panome Bio and CDISC; 1 of its 3 listed competitors has raised funding.
Company details
TheraTraQ delivers competitive intelligence services to biopharma and medical device companies, using interactive platforms for monitoring and analytics from pre-discovery to post-marketing. It operates as an autonomous division within SAI MedPartners, offering customizable solutions like secondary data monitoring and expert support. Based in Reading, PA, USA, it focuses on helping clients navigate the global therapeutic landscape through cost-effective tools and databases.
- Headquarters Reading, United States
- Employees 56
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website theratraq.com
- Social LinkedIn X
- Legal Name Theratraq India Private Limited
- Date of Incorporation 12 Dec, 2019
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹12.17 Cr
FY 2025 · +7% YoY
- Indian entity net profit₹1.58 Cr
FY 2025 · 13% margin
- Indian entity EBITDA₹2.07 Cr
FY 2025 · 17% margin
- Employee Count56
Associated legal entities of TheraTraQ
TheraTraQ operates through Theratraq India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Theratraq India Private Limited CIN U74999KA2019PTC130594 | Active | 12 Dec 2019 | Bangalore, Karnataka | ₹12.2 Cr | 56 | 2 | View details |
Products & Services of TheraTraQ
TheraTraQ offers a comprehensive portfolio of products and services, including IntelliTraQ, PulseTraQ, KOL Match, CellTraQ, and GeneTraQ.
Platform for monitoring and analyzing biopharma landscapes.
Tool for tracking industry trends and competitive data.
Service for connecting with key opinion leaders in healthcare.
Database for cell therapy and related research insights.
Database focused on gene therapy and genetic analytics.
Analytics for managing supply chains in biopharma.
Board of directors of Theratraq India Private Limited (TheraTraQ)
Theratraq India Private Limited is the primary company behind TheraTraQ. The board of Theratraq India Private Limited currently have 2 directors; the longest-serving is Akshay Krishnamachari, appointed in 2019. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Akshay Krishnamachari DIN 08637416 | Managing Director | 12 Dec 2019 | 6 yrs 11 mo | Theratraq India Private Limited |
| Neeku Moni Gogoi DIN 08910622 | Director | 27 Oct 2020 | 6 yrs | Theratraq India Private Limited |
People of TheraTraQ
6 people are tracked at TheraTraQ (1 in leadership, 5 in team); the tracked headcount is 56.
| Name | Role | Group |
|---|---|---|
John Barry | Vice President, Global Oncology Strategy | Leadership |
Vishal Ghatge | Senior Manager - Deployment Analyzer | Team |
Aakershita Sharma | Lead - Pulsetraq | Team |
Sharda Rani Sharma | Associate Principal | Team |
| Principal | Team | |
Madan Thapa | Associate Principal | Team |
Complete people profiles for TheraTraQ
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of TheraTraQ
Figures of Theratraq India Private Limited, the primary company behind TheraTraQ, for FY 2025. Revenue was ₹12.17 Cr (+7% year on year). Net profit was ₹1.58 Cr (13% margin). EBITDA was ₹2.07 Cr (17% margin). Revenue has grown at a compounded annual rate of +23% over three years and +97% over five years.
- ₹12.17 CrRevenue · FY 2025 · +7% YoY
- ₹1.58 CrNet profit · 13% margin
- ₹2.07 CrEBITDA · 17% margin
- ₹2.8 LakhPaid-up capital
- 56Employees (provident fund records)
- +23%Revenue CAGR, 3 years
- +97%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Theratraq India Private Limited are on its company page.
Detailed financial statements for TheraTraQ
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of TheraTraQ
TheraTraQ has 3 listed competitors in our database, 1 of them funded. They include Knipper, Panome Bio and CDISC.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| knipper.com | 1986 | Lakewood Township, United States | Provider of diversified outsourcing services for pharmaceutical, biotech, and medical device companies | |||
| panomebio.com | 2022 | St. Louis, United States | $6M | Clinical data analytics services are provided for healthcare applications. | ||
| cdisc.org | 1999 | Austin, United States | Provider of data management services |
Detailed competitors of TheraTraQ
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as TheraTraQ (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 5.33 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about TheraTraQ
TheraTraQ was founded in 2019.
TheraTraQ is headquartered in Reading, United States. It is registered at Reading, Pennsylvania, United States.
TheraTraQ has 56 employees.
The primary company behind TheraTraQ, Theratraq India Private Limited, reported revenue of ₹12.17 Cr for FY 2025, up 7% year on year.
TheraTraQ delivers competitive intelligence services to biopharma and medical device companies, using interactive platforms for monitoring and analytics from pre-discovery to post-marketing. It operates as an autonomous division within SAI MedPartners, offering customizable solutions like secondary data monitoring and expert support. Based in Reading, PA, USA, it focuses on helping clients navigate the global therapeutic landscape through cost-effective tools and databases.
TheraTraQ's top competitors include Knipper, CDISC and Panome Bio.
TheraTraQ offers IntelliTraQ, PulseTraQ, KOL Match, CellTraQ, and 2 more products and services.
TheraTraQ operates through Theratraq India Private Limited.
The legal entities of TheraTraQ currently have 2 directors, including Neeku Moni Gogoi, Akshay Krishnamachari.